Omega-3 fatty acids modulate collagen signaling in human platelets

Area of Science:

• Cardiovascular Science
• Hematology
• Nutrition Science

Background:

• Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to provide cardioprotective benefits.
• The precise cellular and physiological mechanisms underlying these cardiovascular protective effects remain incompletely understood.

Purpose of the Study:

• To investigate whether EPA and DHA treatments interfere with collagen-mediated platelet signaling pathways.
• To explore the cellular basis of the cardioprotective effects of omega-3 fatty acids.

Main Methods:

• Thirty healthy volunteers were supplemented with 3.4 g/d of EPA+DHA for 28 days, with and without a single dose of aspirin.
• Assays were performed to measure collagen-stimulated platelet activation, including integrin activation, α-granule secretion, and phosphatidylserine exposure.
• Collagen-induced tyrosine phosphorylation and clinical hematologic parameters were analyzed.

Main Results:

• Omega-3 supplementation resulted in a minor reduction in platelet and red blood cell counts but did not affect clinical time-to-closure assays.
• Collagen-mediated platelet signaling, including integrin activation, α-granule secretion, and phosphatidylserine exposure, was reduced by approximately 50%.
• Collagen-induced tyrosine phosphorylation was significantly impaired following omega-3 incorporation.

Conclusions:

• Dietary intake of EPA and DHA significantly impairs collagen-mediated platelet signaling pathways.
• The observed reduction in platelet responsiveness to collagen may contribute to the cardioprotective effects attributed to omega-3 fatty acids.
• These findings elucidate a potential cellular mechanism for the cardiovascular benefits of EPA and DHA.